Feature Channels:

AIDS and HIV

Add to Favorites Subscribe Share
fbshare-AIDS and HIV

Showing results

2130 of 1307
Newswise: Immunotherapy drug found safe in treating cancer patients with HIV

Article ID: 713855

Immunotherapy drug found safe in treating cancer patients with HIV

Fred Hutchinson Cancer Research Center

The results of a study led by physicians at Fred Hutchinson Cancer Research Center showed that patients living with HIV and one of a variety of potentially deadly cancers could be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA®.

Released:
3-Jun-2019 2:05 PM EDT
Newswise: Could gold be the key to making gene therapy for HIV, blood disorders more accessible?
  • Embargo expired:
    27-May-2019 11:00 AM EDT

Article ID: 713374

Could gold be the key to making gene therapy for HIV, blood disorders more accessible?

Fred Hutchinson Cancer Research Center

Scientists at Fred Hutchinson Cancer Research Center took a step toward making gene therapy more practical by simplifying the way gene-editing instructions are delivered to cells. Using a gold nanoparticle instead of an inactivated virus, they safely delivered gene-editing tools in lab models of HIV and inherited blood disorders, as reported May 27 in Nature Materials.

Released:
23-May-2019 11:00 AM EDT
HIVMA600_2018blue.png

Article ID: 713512

Allowing Discrimination, Administration Proposals Threaten Transgender Health and Progress Against HIV Epidemic

HIV Medicine Association (HIVMA)

Allowing Discrimination, Administration Proposals Threaten Transgender Health and Progress Against HIV Epidemic

Released:
26-May-2019 6:30 AM EDT

Law and Public Policy

Georgetown_H_GUMC_blueRGB.jpg
  • Embargo expired:
    17-May-2019 11:00 AM EDT

Article ID: 712973

For Many HIV+ Women, Daily Survival Takes Precedence Over Viral Suppression

Georgetown University Medical Center

According to scientists who study women infected with HIV, statistics often paint an impressionist view of the lives of these women that misses the granular detail that tells the real story. The imprecise big picture is that most of this population is doing a good job at suppressing the virus, but facts gathered on the ground show that many struggle with issues of daily living that can make taking a pill to keep HIV at bay difficult.

Released:
16-May-2019 8:30 AM EDT
Newswise: New HIV  vaccine strategy “pumps” the immune system
  • Embargo expired:
    9-May-2019 11:00 AM EDT

Article ID: 712393

New HIV vaccine strategy “pumps” the immune system

La Jolla Institute for Immunology

A new HIV vaccine delivery strategy appears to enhance the protective immune response in a preclinical model. Scientists at the La Jolla Institute for Immunology (LJI) have discovered that delivering an HIV vaccine in small doses over a series of days leads to a stronger immune response than when the same vaccine is given all at once.

Released:
6-May-2019 9:50 AM EDT
HIVMA600_2018blue.png

Article ID: 712379

HHS’s “Conscience Rights” Rule Threatens Public Health

HIV Medicine Association (HIVMA)

HHS’s “Conscience Rights” Rule Threatens Public Health

Released:
4-May-2019 2:05 PM EDT

Social and Behavioral Sciences, Law and Public Policy

Article ID: 712296

Mount Sinai REACH Program to Host Women’s Health Fair

Mount Sinai Health System

In honor of National Women’s Health Week, the REACH Program (Respectful and Equitable Access to Comprehensive Healthcare) at Mount Sinai is hosting a Women’s Health Fair for the Harlem and surrounding communities.

Released:
2-May-2019 1:05 PM EDT
Newswise: International Research Team Led by Pitt Wins $6M Grant to Study HIV and Tuberculosis Coinfection in Children

Article ID: 712217

International Research Team Led by Pitt Wins $6M Grant to Study HIV and Tuberculosis Coinfection in Children

Health Sciences at the University of Pittsburgh

Children with HIV are much more susceptible to TB and also much more likely to die from it. This grant will fund international research to investigate why, both in the lab and in the field.

Released:
1-May-2019 1:05 PM EDT
ubu-logo.gif

Article ID: 712122

Study: Health care providers split on who should prescribe HIV prevention drug

University at Buffalo

University at Buffalo researchers interviewed a small sample of PrEP-prescribing providers in New York State to conduct a qualitative analysis of their perspectives on the preventive medication.

Released:
30-Apr-2019 12:35 PM EDT
Newswise: Georgetown Welcomes Deus Bazira and Colleagues to Lead New Global Health Center

Article ID: 711172

Georgetown Welcomes Deus Bazira and Colleagues to Lead New Global Health Center

Georgetown University Medical Center

Georgetown University Medical Center (GUMC) announces the appointment of Deus Bazira, DrPH, MPH, MBA, BPharm, an expert in health systems strengthening and a public health practitioner with decades of in-depth field level practical experience in global health in emerging economies, to establish and co-direct Georgetown’s new Center for Global Health Practice and Impact (CGHPI).

Released:
15-Apr-2019 11:30 AM EDT

Showing results

2130 of 1307

Chat now!